Regulators favor processes designed with drug quality in mind. The challenge is that as production methods become more complex, established modeling techniques are struggling to cope.
So says Ian Walsh, PhD, staff scientist at the bioprocessing technology institute A*STAR in Singapore,…
Source: www.genengnews.com – Read more
How Automation is Advancing Biosimilar Adoption
Many Americans are struggling with the high costs of biologic medications. Although biosimilars, which are cheaper alternatives, exist, they remain underused due to a lack
